Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study

被引：0
|
作者：
Arnaud Bayle
Laila Belcaid
Lola-Jade Palmieri
Diego Teysonneau
Sophie Cousin
Mariella Spalato-Ceruso
Mihaela Aldea
Damien Vasseur
Melissa Alame
Laura Blouin
Isabelle Soubeyran
Claudio Nicotra
Maud Ngocamus
Antoine Hollebecque
Yohann Loriot
Benjamin Besse
Ludovic Lacroix
Etienne Rouleau
Fabrice Barlesi
Fabrice Andre
Antoine Italiano
机构：
[1] DITEP,Department of Oncology
[2] Gustave Roussy,Department of Medicine
[3] Copenhagen University Hospital,Department of Medicine
[4] Institut Bergonié,Department of Biopathology
[5] Gustave Roussy,Department of Biopathology
[6] Gustave Roussy,Faculty of Medicine
[7] Institut Bergonié,Faculty of Medicine
[8] Paris Saclay University,undefined
[9] University of Bordeaux,undefined
来源：
Molecular Cancer | / 22卷
关键词：
ctDNA; Targeted therapy; Resistance biomarkers; Next-generation sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 40 条
  • [21] Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
    Volkmar Müller
    Sabine Riethdorf
    Brigitte Rack
    Wolfgang Janni
    Peter A Fasching
    Erich Solomayer
    Bahriye Aktas
    Sabine Kasimir-Bauer
    Klaus Pantel
    Tanja Fehm
    Breast Cancer Research, 14
  • [22] Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study
    Goncalves, Anthony
    Bertucci, Francois
    Guille, Arnaud
    Garnier, Severine
    Adelaide, Jose
    Carbuccia, Nadine
    Cabaud, Oliver
    Finetti, Pascal
    Brunelle, Serge
    Piana, Gilles
    Tomassin-Piana, Jeanne
    Paciencia, Maria
    Lambaudie, Eric
    Popovici, Cornel
    Sabatier, Renaud
    Tarpin, Carole
    Provansal, Magali
    Extra, Jean-Marc
    Eisinger, Francois
    Sobol, Hagay
    Viens, Patrice
    Lopez, Marc
    Ginestier, Christophe
    Charafe-Jauffret, Emmanuelle
    Chaffanet, Max
    Birnbaum, Daniel
    ONCOTARGET, 2016, 7 (48) : 79414 - 79427
  • [23] A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer
    Kasi, P. M.
    Sawyer, S.
    Guilford, J.
    Munro, M.
    Ellers, S.
    Hook, N.
    Krinshpun, S.
    Moshkevich, S.
    Billings, P. R.
    Aleshin, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S459 - S459
  • [24] Combination of highly-sensitive ddPCR-assays and NGS allow detection and monitoring of circulating tumor DNA in plasma of patients with advanced colorectal cancer receiving targeted therapies
    Deuter, M.
    Schlenker, F.
    Hussung, S.
    Philipp, U.
    Jolic, M.
    Kipf, E.
    Hoeffkes, I
    Follo, M.
    Souchon, S.
    Gumenscheimer, M.
    Duque-Afonso, J.
    Becker, H.
    Fritsch, R.
    Axt, F.
    Mitschke, J.
    Marschner, N.
    Juelg, P.
    Borst, N.
    Hutzenlaub, T.
    Zengerle, R.
    von Stetten, F.
    Duyster, J.
    Wehrle, J.
    Scherer, F.
    von Bubnoff, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 216 - 217
  • [25] Circulating tumor DNA analysis for predictive and prognostic factors in patients with metastatic colorectal cancer: An exploratory analysis from the phase III PARADIGM study
    Tsuchihara, Katsuya
    Muro, Kei
    Yoshino, Takayuki
    Shitara, Kohei
    Yamazaki, Kentaro
    Ota, Mitsuyoshi
    Oki, Eiji
    Sato, Takeo
    Naitoh, Takeshi
    Komatsu, Yoshito
    Kato, Takeshi
    Yamanaka, Kazunori
    Mori, Ikuo
    Hihara, Masamitsu
    Soeda, Jumpei
    Badola, Sunita
    Shin, Hyunjin
    Yamanaka, Takeharu
    Akagi, Kiwamu
    Ochiai, Atsushi
    Uetake, Hiroyuki
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Detection of co-occurring and potential resistance mutations in cell-free, circulating tumor DNA from patients with BRAFmutant metastatic melanoma undergoing treatment with BRAF-targeted therapies
    Corless, Broderick
    Chang, Greg
    Liu, Weihua
    Li, Jin
    Marziali, Andre
    Mai, Laura
    Wiggin, Matthew
    Wilson, Melissa
    Pavlick, Anna
    Osman, Iman
    Karlin-Neumann, George
    Spittle, Cindy
    Polsky, David
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Prognostic significance of tumor DNA ploidy in intermediate-risk endometrioid endometrial cancer: A study of 1053 patients from a tertiary referral center
    Tabbaa, Z.
    Dowdy, S.
    Podratz, K.
    Bakkum-Gamez, J.
    Cliby, W.
    Kumar, S.
    Keeney, G.
    Weaver, A.
    McGree, M.
    Mariani, A.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S159 - S159
  • [28] Prognostic Impact of Circulating Tumor Cells Assessed with the Cell Search Assay and Adna Test Breast in Metastatic Breast Cancer Patients - The DETECT Study.
    Mueller, V.
    Riethdorf, S.
    Rack, B.
    Wolfgang, J.
    Fasching, P. A.
    Solomayer, E.
    Aktas, B.
    Kasimir-Bauer, S.
    Mury, D.
    Pantel, K.
    Fehm, T.
    CANCER RESEARCH, 2011, 71
  • [29] Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer
    Zhang, Yujun
    Xiong, Liwen
    Xie, Fangfang
    Zheng, Xiaoxuan
    Li, Ying
    Zhu, Lei
    Sun, Jiayuan
    CANCER MEDICINE, 2021, 10 (14): : 4697 - 4709
  • [30] PLCRC-PROVENC3 study: Prognostic value of post-surgery liquid biopsy circulating tumor DNA in stage III colon cancer patients
    Rubio-Alarcon, C.
    Franken, I. A.
    van Nassau, S. C. M. W.
    Schraa, S.
    Meiqari, L.
    Ketelaars, S.
    Velculescu, V.
    Angiuoli, S.
    Georgiadis, A.
    Riley, D.
    Greco, C.
    Van Den Broek, D.
    Punt, C. J. A.
    Coupe, V.
    Koopman, M.
    Roodhart, J. M. L.
    Meijer, G.
    Sausen, M.
    Vink, G. R.
    Fijneman, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S427 - S428
1234